{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:33:01Z","timestamp":1793068381938,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,27]],"date-time":"2027-10-27T00:00:00Z","timestamp":1824595200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.semperi.2026.152250","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:25:37Z","timestamp":1778959537000},"page":"152250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rebalancing prostanoids: How differential COX-1 and COX-2 inhibition explains the success and limitations of low-dose aspirin in pregnancy"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-4417","authenticated-orcid":false,"given":"Kristen Lee","family":"Moriarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupsa C.","family":"Boelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semperi.2026.152250_bib0001","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/eurheartj\/ehy872","article-title":"The remarkable story of a wonder drug, which now comes to an end in the primary prevention setting: say bye-bye to aspirin!","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"},{"issue":"3-4","key":"10.1016\/j.semperi.2026.152250_bib0002","first-page":"131","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"14","author":"McGarry","year":"1987","journal-title":"Clin Exp Obs Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0003","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obs Gynecol"},{"issue":"12","key":"10.1016\/j.semperi.2026.152250_bib0004","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Force","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0005","doi-asserted-by":"crossref","first-page":"336.e1","DOI":"10.1016\/j.ajog.2022.09.006","article-title":"Low-dose aspirin use in pregnancy and the risk of preterm birth: a Swedish register-based cohort study","volume":"228","author":"Kupka","year":"2023","journal-title":"Am J Obs Gynecol"},{"issue":"2","key":"10.1016\/j.semperi.2026.152250_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obs Gynecol"},{"issue":"7","key":"10.1016\/j.semperi.2026.152250_bib0007","article-title":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obs Gynecol MFM"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0008","doi-asserted-by":"crossref","first-page":"315.e1","DOI":"10.1016\/j.ajog.2024.06.038","article-title":"Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open-label randomized trial (ASPREO)","volume":"232","author":"Amro","year":"2025","journal-title":"Am J Obs Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0009","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000006218","article-title":"Comparison of 162 mg and 81 mg Aspirin for prevention of preeclampsia: a randomized controlled trial","volume":"147","author":"Huang","year":"2026","journal-title":"Obs Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/uog.23668","article-title":"ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis","volume":"58","author":"Shen","year":"2021","journal-title":"Ultrasound Obs Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2026.152250_bib0011","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1002\/mco2.363","article-title":"Arachidonic acid metabolism in health and disease","volume":"4","author":"Zhang","year":"2023","journal-title":"MedComm (2020)"},{"issue":"5","key":"10.1016\/j.semperi.2026.152250_bib0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.plefa.2003.07.003","article-title":"COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics?","volume":"69","author":"Schwab","year":"2003","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0013","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd1929","article-title":"COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs","volume":"5","author":"Mitchell","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0014","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9378(11)91660-3","article-title":"Changes in expression of the cyclooxygenase gene in human fetal membranes and placenta with labor","volume":"167","author":"Bennett","year":"1992","journal-title":"Am J Obs Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0015","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obs Gynecol"},{"issue":"18","key":"10.1016\/j.semperi.2026.152250_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13185647","article-title":"Placental gene therapy for fetal growth restriction and preeclampsia: preclinical studies and prospects for clinical application","volume":"13","author":"Majumder","year":"2024","journal-title":"J Clin Med"},{"issue":"22","key":"10.1016\/j.semperi.2026.152250_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211091","article-title":"Late vs. Early preeclampsia","volume":"26","author":"Kariori","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2S","key":"10.1016\/j.semperi.2026.152250_bib0018","doi-asserted-by":"crossref","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","article-title":"Animal models of preeclampsia: investigating pathophysiology and therapeutic targets","volume":"226","author":"Bakrania","year":"2022","journal-title":"Am J Obs Gynecol"},{"issue":"7","key":"10.1016\/j.semperi.2026.152250_bib0019","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0020","doi-asserted-by":"crossref","DOI":"10.1080\/10641955.2024.2358761","article-title":"Gene therapy in preeclampsia: the dawn of a new era","volume":"43","author":"Sun","year":"2024","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0021","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1073\/pnas.1018164108","article-title":"Preeclampsia: animal models for a human cure","volume":"108","author":"Aubuchon","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.semperi.2026.152250_bib0022","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijgo.2015.10.024","article-title":"Association between the maternal serum levels of 19 eicosanoids and pre-eclampsia","volume":"133","author":"Long","year":"2016","journal-title":"Int J Gynaecol Obs"},{"issue":"2","key":"10.1016\/j.semperi.2026.152250_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bcpt.13308","article-title":"Aspirin for the prevention and treatment of pre-eclampsia: a matter of COX-1 and\/or COX-2 inhibition?","volume":"127","author":"Mirabito Colafella","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"10.1016\/j.semperi.2026.152250_bib0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.20344\/amp.15995","article-title":"Analysis of the cochrane review: antiplatelet agents for preventing pre-eclampsia and its complications","volume":"34","author":"Reis de Carvalho","year":"2021","journal-title":"Acta Med Port"},{"issue":"13","key":"10.1016\/j.semperi.2026.152250_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134801","article-title":"IJMS special issue \"molecular and cellular mechanisms of preeclampsia\"-editorial","volume":"21","author":"Huppertz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semperi.2026.152250_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.preghy.2018.07.009","article-title":"Aspirin use during pregnancy and hypoxia-related placental pathology","volume":"14","author":"Ye","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"18","key":"10.1016\/j.semperi.2026.152250_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184370","article-title":"Molecular targets of aspirin and prevention of preeclampsia and their potential association with circulating extracellular vesicles during pregnancy","volume":"20","author":"Dutta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.semperi.2026.152250_bib0029","doi-asserted-by":"crossref","unstructured":"Mahajan V., Kumar A., Jacob J., et al. From stress to survival: trophoblast-derived extracellular vesicle proteome captures aspirin-driven cellular reprogramming in a preeclampsia model. bioRxiv 2026. DOI: 10.64898\/2026.03.08.710202.","DOI":"10.64898\/2026.03.08.710202"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/a-2677-6668","article-title":"Platelet-associated microRNAs as markers of Aspirin response and pregnancy outcome in pregnancies at high-risk for preeclampsia","volume":"43","author":"Boelig","year":"2026","journal-title":"Am J Perinatol"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0032","doi-asserted-by":"crossref","first-page":"344.e1","DOI":"10.1016\/j.ajog.2023.12.028","article-title":"Aspirin pharmacokinetics and pharmacodynamics through gestation","volume":"231","author":"Boelig","year":"2024","journal-title":"Am J Obs Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0033","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40262-017-0611-8","article-title":"Obesity and altered aspirin pharmacology","volume":"57","author":"Norgard","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0034","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obs Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70167","article-title":"Pharmacodynamics of Aspirin through gestation: predictors of Aspirin response and association with pregnancy outcome, a prospective cohort study","volume":"18","author":"Boelig","year":"2025","journal-title":"Clin Transl Sci"},{"issue":"9","key":"10.1016\/j.semperi.2026.152250_bib0036","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1055\/s-0042-1743469","article-title":"Aspirin for primary cardiovascular prevention in patients with diabetes: uncertainties and opportunities","volume":"122","author":"Del Bianco-Rondeau","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semperi.2026.152250_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103320","article-title":"Low dose Aspirin in high-risk pregnancies: the volatile effect of acetylsalicylic acid on the inhibition of platelets uncovered by G. Born's light transmission aggregometry","volume":"145","author":"Stern","year":"2021","journal-title":"J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.semperi.2026.152250_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2025.100085","article-title":"Platelet protease-activated receptor 4 genotype and response to aspirin in pregnancy","volume":"2","author":"Boelig","year":"2025","journal-title":"Blood Vessel Thromb Hemost"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0039","first-page":"1888","article-title":"Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia","volume":"80","author":"Walsh","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semperi.2026.152250_bib0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.preghy.2021.09.003","article-title":"Low-dose aspirin increases 15-epi-lipoxins A(4) in pregnancies at high-risk for developing preeclampsia","volume":"26","author":"Gonzalez-Brown","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"10.1016\/j.semperi.2026.152250_bib0041","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1152\/physiolgenomics.00115.2017","article-title":"Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH\/5 mouse model of preeclampsia","volume":"50","author":"Reijnders","year":"2018","journal-title":"Physiol Genom"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0042","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ki.1995.6","article-title":"Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells","volume":"47","author":"Hughes","year":"1995","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065498","article-title":"Landscape of transcriptional deregulations in the preeclamptic placenta","volume":"8","author":"Vaiman","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.semperi.2026.152250_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13207","article-title":"Role of aspirin-triggered lipoxin A4, aspirin, and salicylic acid in the modulation of the oxidative and inflammatory responses induced by plasma from women with pre-eclampsia","volume":"83","author":"Gil-Villa","year":"2020","journal-title":"Am J Reprod Immunol"},{"issue":"10","key":"10.1016\/j.semperi.2026.152250_bib0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"10220","key":"10.1016\/j.semperi.2026.152250_bib0046","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"8898","key":"10.1016\/j.semperi.2026.152250_bib0047","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"2S","key":"10.1016\/j.semperi.2026.152250_bib0048","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obs Gynecol"},{"issue":"4","key":"10.1016\/j.semperi.2026.152250_bib0049","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.282.4.356","article-title":"Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study","volume":"282","author":"Mills","year":"1999","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.semperi.2026.152250_bib0050","first-page":"2400","article-title":"Aspirin versus Placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Nicolaides","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semperi.2026.152250_bib0051","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/CS20220182","article-title":"Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage","volume":"136","author":"Mirabito Colafella","year":"2022","journal-title":"Clin Sci (L)"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0052","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/1471-0528.18070","article-title":"L-Arginine and L-Citrulline for prevention and treatment of pre-eclampsia: a systematic review and meta-analysis","volume":"132","author":"Makama","year":"2025","journal-title":"BJOG"},{"key":"10.1016\/j.semperi.2026.152250_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1598691","article-title":"Role of vitamin D in the pathogenesis of early-onset preeclampsia: a narrative review","volume":"12","author":"Zheng","year":"2025","journal-title":"Front Nutr"},{"issue":"11","key":"10.1016\/j.semperi.2026.152250_bib0054","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1210\/jc.2010-0996","article-title":"A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia","volume":"95","author":"Baker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.semperi.2026.152250_bib0055","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.annepidem.2016.09.015","article-title":"Low maternal 25-hydroxyvitamin D concentration increases the risk of severe and mild preeclampsia","volume":"26","author":"Baca","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00250-5","article-title":"Vitamin D deficiency during late pregnancy mediates placenta-associated complications","volume":"11","author":"Raia-Barjat","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0057","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1186\/s12884-024-07081-y","article-title":"Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis","volume":"24","author":"Moghib","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"10.1016\/j.semperi.2026.152250_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113854","article-title":"Could Vitamin D Be effective in prevention of preeclampsia?","volume":"13","author":"Poniedzialek-Czajkowska","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.semperi.2026.152250_bib0059","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1007\/s11033-020-05644-8","article-title":"The relationship among vitamin D, TLR4 pathway and preeclampsia","volume":"47","author":"de Souza","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"5","key":"10.1016\/j.semperi.2026.152250_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051432","article-title":"Vitamin D effects on the immune system from periconception through pregnancy","volume":"12","author":"Schroder-Heurich","year":"2020","journal-title":"Nutrients"},{"issue":"27","key":"10.1016\/j.semperi.2026.152250_bib0061","doi-asserted-by":"crossref","first-page":"19450","DOI":"10.1074\/jbc.M113.467670","article-title":"Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein","volume":"288","author":"Chen","year":"2013","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.semperi.2026.152250_bib0062","first-page":"178","article-title":"New generation antiplatelet therapies to prevent preeclampsiaEndothelial dysfunction, anti-angiogenic factors","author":"Natalie Hannan","year":"2016","journal-title":"Pregnancy Hypertens: Int J Women\u2019s Cardiovasc Health"},{"key":"10.1016\/j.semperi.2026.152250_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1298928","article-title":"Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine's biological mechanisms","volume":"15","author":"Gajic","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.semperi.2026.152250_bib0064","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajog.2006.08.038","article-title":"Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia","volume":"196","author":"Shah","year":"2007","journal-title":"Am J Obs Gynecol"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000526000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000526000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:54:24Z","timestamp":1793066064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000526000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0146000526000406"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2026.152250","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebalancing prostanoids: How differential COX-1 and COX-2 inhibition explains the success and limitations of low-dose aspirin in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2026.152250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152250"}}